Health Technology euglena Co., Ltd. Business Summary
euglena Co., Ltd. engages in the research, development, production and sale of microalgae products. It operates through the Healthcare; and Energy and Environment segments. The Healthcare segment handles the planning and sale of in-house products, food products and cosmetics using algae.The Energy and Environment segment deals with funded research and technology development with a focus on microalgae. It also engages in the development of bio fuel production technology and investment in bio-tech related business. The company was founded by Mitsuru Izumo, Kengo Suzuki and Takuyuki Fukumoto on August 9, 2005 and is headquartered in Tokyo, Japan.
Financial Highlights
Dec 2021
JPY USD Revenue 27,536.30M 250.61M Gross Profit 16,217.95M 147.60M Operating income -5,252.18M -47.80M Income before tax -5,389.96M -49.05M Net income -4,031.15M -36.68M EBITDA -3,498.66M -31.84M Diluted EPS -39.25 -0.35 Dividends Per Share 0 0 Total Assets 61,007.73M 529.78M Total liabilities 40,418.87M 350.99M Total equity 20,583.31M 178.74M Operating cash flow 1,378.49M 12.54M Currency in JPY Currency in USD
Historical Data Sep 2017 Sep 2018 Sep 2019 Sep 2020 Dec 2021 Revenue
13,886.60M
15,174.58M
13,967.67M
13,317.31M
27,536.30M
Gross Profit
10,082.03M
10,755.49M
9,731.69M
9,199.98M
16,217.95M
Operating income
950.93M
-1,379.62M
-7,460.14M
-1,807.72M
-5,252.18M
Income before tax
1,205.53M
-1,109.22M
-9,604.98M
-1,434.22M
-5,389.96M
Net income
785.88M
-1,252.19M
-9,798.56M
-1,486.68M
-4,031.15M
EBITDA
1,413.03M
-613.67M
-6,503.60M
-1,088.90M
-3,498.66M
Diluted EPS
9.38
-14.70
-107.24
-16.00
-39.25
Dividends Per Share
0
0
0
0
0
Total Assets
18,858.06M
21,837.61M
17,199.44M
15,351.09M
61,007.73M
Total liabilities
3,202.78M
5,932.78M
6,365.06M
5,964.33M
40,418.87M
Total equity
15,643.36M
15,900.39M
10,826.65M
9,376.98M
20,583.31M
Operating cash flow
153.75M
-1,238.02M
1,089.39M
-1,217.47M
1,378.49M
Sep 2017 Sep 2018 Sep 2019 Sep 2020 Dec 2021 Revenue
124.77M
137.37M
126.93M
123.50M
250.61M
Gross Profit
90.59M
97.36M
88.44M
85.32M
147.60M
Operating income
8.54M
-12.48M
-67.79M
-16.76M
-47.80M
Income before tax
10.83M
-10.04M
-87.29M
-13.30M
-49.05M
Net income
7.06M
-11.33M
-89.04M
-13.78M
-36.68M
EBITDA
12.69M
-5.55M
-59.10M
-10.09M
-31.84M
Diluted EPS
0.08
-0.13
-0.97
-0.14
-0.35
Dividends Per Share
0
0
0
0
0
Total Assets
167.53M
192.25M
159.14M
145.46M
529.78M
Total liabilities
28.45M
52.23M
58.89M
56.51M
350.99M
Total equity
138.97M
139.98M
100.17M
88.85M
178.74M
Operating cash flow
1.38M
-11.20M
9.90M
-11.29M
12.54M
Valuation Measures
Dec 2021
PER -- ROA -10.55% ROE -26.90% Operating margin -19.07% Profit margin -14.63%
Key executives
President & Representative Director:
Mitsuru Izumo
Executive Officer, Head-Research & Development:
Kengo Suzuki
Manager-Information System:
Shuji Endo
Director, VP & Manager-Corporate Strategy:
Akihiko Nagata
Executive Officer & Head-Healthcare Sales:
Takuyuki Fukumoto Shareholders
IZUMO MITSURU (11.0%)
Nomura Asset Management Co., Ltd. (3.0%)
The Vanguard Group, Inc. (1.9%)
Nikko Asset Management Co., Ltd. (1.5%)
Daiwa Asset Management Co. Ltd. (1.3%)
BlackRock Fund Advisors (1.3%)
Tokyo Century Corp. (0.8%)
Triodos Investment Management BV (Investment Management) (0.8%)
Davy Global Fund Management Ltd. (0.8%)
SUZUKI KENGO (0.7%)
Contact Details Website: http://www.euglena.jp Address:
G-BASE Tamachi 2-3/F,
5-29-11 Shiba,
Tokyo,
108-0014,
Japan
Phone:
+81.3.3453.4907
Related Companies
ILLUMINATE KK
Frembassy, Inc.
LIGUNA KK
MEJ Inc.
Sports Innovation KK
Euglena Restricted Stock Compensation Plan
Euglena Investment Co. Ltd.
HELLSEN, Inc.
HOOK Inc.
euglena Taketomi Ebi Yoshoku KK
Euglena Art KK
Genequest, Inc.
Plant High Technology Institute KK
Yaeyama Shokusan Co., Ltd.
epauler Co., Ltd.
Art Corp. KK
Daikyo Hiryo KK
Chlorella Supply Co., Ltd.
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 27 Jun, 2022
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close